Nomura Holdings’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-95,620
| Closed | -$3.56M | – | 1159 |
|
|
2023
Q1 | $3.56M | Buy |
95,620
+41,070
| +75% | +$1.53M | 0.01% | 306 |
|
|
2022
Q4 | $2.47M | Buy |
54,550
+27,827
| +104% | +$1.26M | 0.01% | 369 |
|
|
2022
Q3 | $1.87M | Sell |
26,723
-110,917
| -81% | -$7.78M | 0.01% | 476 |
|
|
2022
Q2 | $9.74M | Buy |
137,640
+115,601
| +525% | +$8.18M | 0.03% | 192 |
|
|
2022
Q1 | $1.88M | Buy |
+22,039
| New | +$1.88M | 0.01% | 563 |
|
|
2021
Q2 | – | Sell |
-4,500
| Closed | -$770K | – | 1921 |
|
|
2021
Q1 | $770K | Buy |
4,500
+3,294
| +273% | +$564K | ﹤0.01% | 842 |
|
|
2020
Q4 | $265K | Sell |
1,206
-681
| -36% | -$150K | ﹤0.01% | 954 |
|
|
2020
Q3 | $313K | Sell |
1,887
-1,613
| -46% | -$268K | ﹤0.01% | 774 |
|
|
2020
Q2 | $399K | Buy |
+3,500
| New | +$399K | ﹤0.01% | 643 |
|